window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : June 13, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Clinical & Regulatory

  • Clinical & Regulatory,Medical devices,Therapeutic Areas

    Laser therapy reduces bacterial load in burn wounds, study shows

    A single photobiomodulation session reduced bacterial load in acute burn [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Therapeutic Areas

    Ethris part of EU consortium to advance novel pandemic influenza vaccine

    Munich-based Ethris GmbH is part of a seven-organisation European consortium [...]

    May 5, 2026
  • Clinical & Regulatory,Therapeutic Areas

    Rare Disease Day 2026: Cereno Scientific advances disease-modifying therapies in PAH

    As Rare Disease Day 2026 shines a spotlight on patients [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Opinion & Events,Therapeutic Areas

    ViiV Healthcare reports 12-month data showing lotivibart maintains viral suppression in ultra long-acting HIV regimen

    ViiV Healthcare, the global specialist HIV company majority owned by [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Opinion & Events,Therapeutic Areas

    Young adults in US, UK and Australia hit hardest by global mental health decline

    Young adults in wealthy countries are four times more likely [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Drug Delivery & Formulation,Therapeutic Areas

    Study confirms Nerivio REN wearable safe with continuous glucose monitoring devices

    A new study confirms that Theranica’s Nerivio REN wearable for [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    SolasCure phase 2 trial shows faster healing in venous leg ulcers

    SolasCure has reported positive phase 2 data for Aurase Wound [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    AC Immune doses first participant in Phase 1 trial of NLRP3 inhibitor ACI-19764

    AC Immune has initiated a Phase 1 trial of its [...]

    May 5, 2026
  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas

    Fennec presents real world data on Pedmark use in head and neck cancer

    Fennec Pharmaceuticals has presented real world data supporting the integration [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas

    Almirall meets guidance with 12.4% net sales growth and dermatology portfolio progress in 2025

    Almirall delivered net sales growth of 12.4% in 2025, surpassing [...]

    May 5, 2026
Previous8910Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • CuraCell reports pancreatic cancer findings from personalised TIL therapy programme
    Categories: Advanced Therapies, Clinical & Regulatory, Therapeutic Areas
  • Nebu~Flow secures £2M Scottish Enterprise grant for nebuliser technology
    Categories: Drug Delivery & Formulation, Medical devices, Pharmaceuticals and therapeutics
  • Apoha raises $36M to expand molecular behaviour data platform
    Categories: Biotech & Pharma Business, Digital & Data, Drug Discovery & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top